TOKYO - JAPAN sent a team of health experts on Sunday to Canada to investigate allergic reactions to swine flu vaccinations from British pharmaceutical giant GlaxoSmithKline (GSK).
The World Health Organization said last week that an unusual number of severe allergic reactions to H1N1 flu vaccinations have been recorded in Canada, where a batch of the vaccine from GSK has been recalled.
The team from the health and welfare ministry was seen departing from Tokyo's Narita airport. It is scheduled to spend four days in Canada to study precautionary measures against allergic reactions.
Tokyo has ordered doses of GSK-made vaccinations for 37 million people, a shipment due for delivery in December in a country that has a limited supply of domestically-made prophylactics.
Japan started vaccinating medical workers against H1N1 flu in October.
Since May, the A(H1N1) virus is known to have killed 70 people in the country, which is now heading into the autumn-winter flu season. -- AFP